Vitality Smartcable
Commercial- Indications
- COVID-19, Epilepsy, Depression, Treatment-resistant depression
Company intelligence / Profile preview
Nemechek Technologies develops and markets the Vitality Smartcable®, a smartphone-enabled, non-invasive vagus nerve stimulator designed to reduce inflammation and improve overall health. The company has published research on the use of vagus nerve stimulation for reducing inflammatory cytokines and has initiated or proposed clinical trials targeting COVID‑19-related cytokine storms. Their product is available direct-to-consumer as a wellness device; no prescription required for purchase. Clinical results are primarily focused on heart rate variability improvements and reduction of pro-inflammatory markers, with ongoing exploration in acute settings like COVID‑19.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nemechek Technologies.